Avicanna Announces Filing of Annual Financial Statements For Year Ended December 31, 2020
TORONTO, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, announces the filing of the Company’s audited annual financial statements for the year ended December 31, 2020, and accompanying management’s discussion and analysis, annual information form and related certifications (collectively, the “Documents”). Electronic copies of the Documents are available on SEDAR (www.sedar.com) under the Company’s issuer profile.
- Electronic copies of the Documents are available on SEDAR (www.sedar.com) under the Companys issuer profile.
- For more information about Avicanna, visit www.avicanna.com , call 1-647-243-5283, or contact Setu Purohit, President by email at [email protected] .
- Actual results and developments may differ materially from those contemplated by these statements.
- The statements in this press release are made as of the date of this release.